Novel interactions of the mineralocorticoid receptor

Molecular and Cellular Endocrinology

Volumn 408, Issue , 2015, Pages 33-37

  Fuller, Peter J ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Aldosterone; Coactivators; Corticosteroids; Cortisol; N C interaction

Indexed keywords

LIGAND; MINERALOCORTICOID RECEPTOR; PROTEIN BINDING;

ANIMAL; CHEMISTRY; HUMAN; METABOLISM; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

ANIMALS; HUMANS; LIGANDS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, MINERALOCORTICOID; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 84938285139     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.01.027     Document Type: Review

References (58)

1. Bledsoe R.K., Madauss K.P., Holt J.A., Apolito C.J., Lambert M.H., Pearce K.H., et al. A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor. J. Biol. Chem 2005, 280:31283-31293.
2. Bledsoe R.K., Montana G., Stanley T.B., Delves C.J., Apolito C.J., McKee D.D., et al. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 2002, 110:93-105.
3. Bookout A.L., Jeong Y., Downes M., Yu R.T., Evans R.M., Mangelsdorf D.J. Anatomical profiling of nuclear receptor expression revealsa hierarchical transcriptional network. Cell 2006, 126:789-799.
4. Bruner K.L., Derfoul A., Robertson N.M., Guerriero G., Fernandes-Alnemri T., Alnemri E.S., et al. The unliganded mineralocorticoid receptor is associated with heat shock proteins 70 and 90 and the immunophilin FKBP-52. Recept. Signal Transduct 1997, 7:85-98.
5. Caldenhoven E., Liden J., Wissink S., Vandestolpe A., Raaijmakers J., Koenderman L., et al. Negative cross-talk between ReIA and the glucocorticoid receptor - a possible mechanism for the anti-inflammatory action of glucocorticoids. Mol. Endocrinol 1995, 9:401-412.
6. Caprio M., Newfell B.G., la Sala A., Baur W., Fabbri A., Rosano G., et al. Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion. Circ. Res 2008, 102:1359-1367.
7. Chantong B., Kratschmar D.V., Nashev L.G., Balazs Z., Odermatt A. Mineralocorticoid and glucocorticoid receptors differentially regulate NF-kappaB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells. J. Neuroinflammation 2012, 9:260.
8. Clyne C.D., Chang C.-Y., Safi R., Fuller P.J., McDonnell D.P., Young M.J. Purification and characterization of recombinant human mineralocorticoid receptor. Mol. Cell. Endocrinol 2009, 302:81-85.
9. De Bosscher K., Vanden Berghe W., Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-κB or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev 2003, 24:488-522.
10. Dooley R., Harvey B.J., Thomas W. Non-genomic actions of aldosterone: from receptors and signals to membrane targets. Mol. Cell. Endocrinol 2012, 350:223-234.
11. Fagart J., Huyet J., Pinon G.M., Rochel M., Mayer C., Rafestin-Oblin M.-E. Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension. Nat. Struct. Mol. Biol 2005, 12:554-555.
12. Fagart J., Hillisch A., Huyet J., Barfacker L., Fay M., Pleiss U., et al. A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule. J. Biol. Chem 2010, 285:29932-29940.
13. Feldman R.D., Gros R. Vascular effects of aldosterone: sorting out the receptors and the ligands. Clin. Exp. Pharmacol. Physiol 2013, 40:916-921.
14. Fischer K., Kelly S.M., Watt K., Price N.C., McEwan I.J. Conformation of the mineralocorticoid receptor N-terminal domain: evidence for induced and stable structure. Mol. Endocrinol 2010, 24:1935-1948.
15. Fuller P.J., Young M.J. Mechanisms of mineralocorticoid action. Hypertension 2005, 46:1227-1235.
16. Geerling J.C., Loewy A.D. Aldosterone in the brain. Am. J. Physiol. Renal Physiol 2009, 297:F559-F576.
17. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 2000, 14:121-141.
18. Gomez-Sanchez E.P., Venkataraman M.T., Thwaites D., Fort C. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am. J. Physiol 1990, 258:E649-E653.
19. Green S., Chambon P. Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptor. Nature 1987, 325:75-78.
20. Gronemeyer H., Gustafsson J.Å., Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat. Rev. Drug Discov 2004, 3:950-964.
21. Grossmann C., Gekle M. Interaction between mineralocorticoid receptor and epidermal growth factor receptor signaling. Mol. Cell. Endocrinol 2012, 350:235-241.
22. Hudson W.H., Youn C., Ortlund E.A. Crystal structure of the mineralocorticoid receptor DNA binding domain in complex with DNA. PLoS ONE 2014, 9(9):e107000.
23. Hultman M.L., Krasnoperova N.V., Li S., Du S., Xia C., Dietz J.D., et al. The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms. Mol. Endocrinol 2005, 19:1460-1473.
24. Juurlink D.N., Mamdani M.M., Lee D.S., Kopp A., Austin P.C., Laupacis A., et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N. Engl. J. Med 2004, 351:543-551.
25. Kolla V., Litwack G. Inhibition of mineralocorticoid-mediated transcription by NF-[kappa]B. Arch. Biochem. Biophys 2000, 383:38-45.
26. Langley E., Zhou Z.X., Wilson E.M. Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J. Biol. Chem 1995, 270:29983-29990.
27. Leroy V., de Seigneux S., Agassiz V. Aldosterone activates NF-kappaB in the collecting duct. J. Am. Soc. Nephrol 2009, 20:131-144.
28. Levin E.R. G protein-coupled receptor 30: estrogen receptors or collaboration?. Endocrinology 2009, 150:1563-1565.
29. Li Y., Suino K., Daugherty J., Xu H.E. Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor. Mol. Cell 2005, 19:367-380.
30. Liden J., Delaunay F., Rafter I., Gustafsson J., Okret S. A new function for the C-terminal zinc finger of the glucocorticoid receptor. J. Biol. Chem 1997, 272:21467-21472.
31. Luisi B.F., Xu W.X., Otwinowski Z., Freedman L.P., Yamamoto K.R., Sigler P.B. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 1991, 352:497-505.
32. Martinez E.D., Pattabiraman N., Danielsen M. Analysis of the hormone-binding domain of steroid receptors using chimeras generated by homologous recombination. Exp. Cell Res 2005, 308:320-333.
33. Marzolla V., Armani A., Zennaro M.-C., Cinti F., Mammi C., Fabbri A., et al. The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism. Mol. Cell. Endocrinol 2012, 350:281-288.
34. Meijer O.C., Williamson A., Dallman M.F., Pearce D. Transcriptional repression of the 5-HTIA receptor promoter by corticosterone via mineralocorticoid receptors depends on the celllular context. J. Neuroendocrinol 2000, 12:245-254.
35. Metivier R., Penot G., Flouriot G., Pakdel F. Synergism between ER (alpha) transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1; requirement for the AF-1 (alpha)-helical core and for a direct interaction between the N- and C-terminal domains. Mol. Endocrinol 2001, 15:1953-1970.
36. Mihailidou A.S. Nongenomic actions of aldosterone: physiological or pathophysiological role?. Steroids 2006, 71:277-280.
37. Odermatt A., Kratschmar D.V. Tissue-specific modulation of mineralocorticoid receptor function by 11β-hydroxysteroid dehydrogenases: an overview. Mol. Cell. Endocrinol 2012, 350:168-186.
38. Pearce D., Yamamoto K.R. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 1993, 259:1161-1165.
39. Pippal J.B., Yao Y.-Z., Rogerson F.M., Fuller P.J. Structural and functional characterization of the interdomain interaction in the mineralocorticoid receptor. Mol. Endocrinol 2009, 23:1360-1370.
40. Pippal J.B., Cheung C.M.I., Yao Y.-Z., Brennan F.E., Fuller P.J. Characterization of the zebrafish (Danio rerio) mineralocorticoid receptor. Mol. Cell. Endocrinol 2011, 332:58-66.
41. Rickard A.J., Morgan J., Tesch G., Funder J.W., Fuller P.J., Young M.J. Deletion of mineralocorticoid receptors from macrophages protects against DOC/salt-induced cardiac fibrosis and increased blood pressure. Hypertens 2009, 54:537-543.
42. Robin-Jagerschmidt C., Wurtz J.-M., Guillot B., Gofflo D., Benhamou B., Vergezac A., et al. Residues in the ligand binding domain that confer progestin or glucocorticoid specificity and nodulate the receptor transactivation capacity. Mol. Endocrinol 2000, 14:1028-1037.
43. Rogerson F.M., Fuller P.J. Interdomain interactions in the mineralocorticoid receptor. Mol. Cell. Endocrinol 2003, 200:45-55.
44. Rogerson F.M., Dimopoulos N., Sluka P., Chu S., Curtis A.J., Fuller P.J. Structural determinants of aldosterone binding selectivity in the mineralocorticoid receptor. J. Biol. Chem 1999, 274:36305-36311.
45. Rogerson F.M., Yao Y.-Z., Elsass R.E., Dimopoulos N., Smith B.J., Fuller P.J. A critical region in the mineralocorticoid receptor for aldosterone binding and activation by cortisol: evidence for a common mechanism governing ligand binding specificity in steroid hormone receptors. Mol. Endocrinol 2007, 21:817-828.
46. Rogerson F.M., Yao Y.-Z., Young M.J., Fuller P.J. Identification and characterization of a ligand-selective mineralocorticoid receptor coactivator. FASEB J. 2014, 28:4200-4210.
47. Sato A., Funder J.W. High glucose stimulates aldosterone-induced hypertrophy via type 1 mineralocorticoid receptors in neonatal rat cardiomyocytes. Endocrinology 1996, 137:4145-4153.
48. Shibata S., Rinehart J., Zhang J., Moeckel G., Castaňeda-Bueno M., Stiegler A.L., et al. Mineralocorticoid receptor phosphorylation regulates ligand binding and renal response to volume depletion and hyperkalemia. Cell Metab 2013, 18:660-671.
49. Terada Y., Ueda S., Hamada K., Shimamura Y., Ogata K., Inoue K., et al. Aldosterone stimulates nuclear factor-kappaB activity and transcription of intercellular adhesion molecule-1 and connective tissue browth factor in rat mesangial cells via serum- and glucocorticoid-inducible protein kinase-1. Clin. Exp. Nephrol 2012, 16:81-88.
50. Tetel M.J., Giangrande P.H., Leonhardt S.A., McDonnell D.P., Edwards D.P. Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. Mol. Endocrinol 1999, 13:910-924.
51. Thompson J., Saatcioglu F., Janne O.A., Palvimo J.J. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity. Mol. Endocrinol 2001, 15:923-935.
52. Vivat V., Gofflo D., Wurtz J.-M., Bourguet W., Philibert D., Gronemeyer H. Sequences in the ligand-binding domains of the human androgen and progesterone receptors which determine their distinct ligand identities. J. Mol. Endocrinol 1997, 18:147-160.
53. Wissink S., Meijer O., Pearce D., van der Burg B., van der Saag P.T. Regulation of the rat serotonin-1A receptor gene by corticosteroids. J. Biol. Chem 2000, 275:1321-1326.
54. Yang J., Fuller P.J. Interactions of the mineralocorticoid receptor - Within and without. Mol. Cell. Endocrinol 2012, 350:196-205.
55. Yang J., Chang C.Y., Safi R., Morgan J., McDonnell D.P., Fuller P.J., et al. Identification of ligand-selective peptide antagonists of the mineralocorticoid receptor using phage display. Mol. Endocrinol 2011, 25:32-43.
56. Young M.J., Rickard A.J. Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis. Mol. Cell. Endocrinol 2012, 350:248-255.
57. Zannad F., McMurray J.J.V., Krum H., van Veldhuisen D.J., Swedberg K., Shi H., et al. Eplerenone in patients with systolic heart failure and mild symptoms. N. Engl. J. Med 2010, 364:11-21.
58. Zhou Z.X., Lane M.V., Kemppainen J.A., French F.S., Wilson E.M. Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol. Endocrinol 1995, 9:208-218.